Abstract/Scope of Chapter
This chapter presents an overview to the morphologic findings in normal and disease states in the bone marrow (BM). We begin with a discussion of the maturation and function of the normal marrow elements. The effects of microanatomical localization of hematopoietic elements in relation to specialized stromal cell types on promoting growth and maturation are considered.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cheson BD, Pfistner B, Juweid ME, et al. Revised response criteria for malignant lymphoma. J Clin Oncol 2007;25:579-86.
Metcalfe DD. Mast cells and mastocytosis. Blood 2008;112:946-56.
Tavassoli M, Aoki M. Localization of megakaryocytes in the bone marrow. Blood Cells 1989;15:3-14.
Tefferi A, Thiele J, Orazi A, et al. Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel. Blood 2007;110:1092-7.
Thiele J, Kvasnicka HM, Facchetti F, Franco V, van der Walt J, Orazi A. European consensus on grading bone marrow fibrosis and assessment of cellularity. Haematologica 2005;90:1128-32.
Tavassoli M. Structural alterations of marrow during inflammation. Blood Cells 1987;13:251-61.
Lichtman MA, Chamberlain JK, Weed RI, Pincus A, Santillo PA. The regulation of the release of granulocytes from normal marrow. Prog Clin Biol Res 1977;13:53-75.
Inoue S, Osmond DG. Basement membrane of mouse bone marrow sinusoids shows distinctive structure and proteoglycan composition: a high resolution ultrastructural study. Anat Rec 2001;264:294-304.
Wickramasinghe SN. Observations on the ultrastructure of sinusoids and reticular cells in human bone marrow. Clin Lab Haematol 1991;13:263-78.
Jones E, McGonagle D. Human bone marrow mesenchymal stem cells in vivo. Rheumatology (Oxford) 2008;47:126-31.
Zhang N, Mustin D, Reardon W, et al. Blood-borne stem cells differentiate into vascular and cardiac lineages during normal development. Stem Cells Dev 2006;15:17-28.
Cattoretti G, Schiro R, Orazi A, Soligo D, Colombo MP. Bone marrow stroma in humans: anti-nerve growth factor receptor antibodies selectively stain reticular cells in vivo and in vitro. Blood 1993;81:1726-38.
Petit I, Szyper-Kravitz M, Nagler A, et al. G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4. Nat Immunol 2002;3:687-94.
Vadhan-Raj S, Cohen V, Bueso-Ramos C. Thrombopoietic growth factors and cytokines. Curr Hematol Rep 2005;4:137-44.
Cortelezzi A, Colombo G, Pellegrini C, et al. Bone marrow glycophorin-positive erythroid cells of myelodysplastic patients responding to high-dose rHuEPO therapy have a different gene expression pattern from those of nonresponders. Am J Hematol 2008;83:531-9.
Pastos KM, Slayton WB, Rimsza LM, Young L, Sola-Visner MC. Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes. Blood 2006;108:3360-2.
Zeng SM, Murray JC, Widness JA, Strauss RG, Yankowitz J. Association of single nucleotide polymorphisms in the thrombopoietin-receptor gene, but not the thrombopoietin gene, with differences in platelet count. Am J Hematol 2004;77:12-21.
Igarashi T, Kobayashi Y, Ogura M, et al. Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a Japanese phase II study. Ann Oncol 2002;13:928-43.
Campbell JK, Matthews JP, Seymour JF, Wolf MM, Juneja SK. Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. Ann Oncol 2003;14:273-6.
Franco V, Tripodo C, Rizzo A, Stella M, Florena AM. Bone marrow biopsy in Hodgkin’s lymphoma. Eur J Haematol 2004;73:149-55.
DiGiuseppe JA, Borowitz MJ. Clinical utility of flow cytometry in the chronic lymphoid leukemias. Semin Oncol 1998;25:6-10.
Harmening DM. In: Clinical hematology and fundamentals of hemostasis. 5th ed. Philadelphia, PA: F. A. Davis, 2009.
Thiele J, Zirbes TK, Kvasnicka HM, Fischer R. Focal lymphoid aggregates (nodules) in bone marrow biopsies: differentiation between benign hyperplasia and malignant lymphoma-a practical guideline. J Clin Pathol 1999;52:294-300.
Horny HP, Wehrmann M, Griesser H, Tiemann M, Bultmann B, Kaiserling E. Investigation of bone marrow lymphocyte subsets in normal, reactive, and neoplastic states using paraffin-embedded biopsy specimens. Am J Clin Pathol 1993;99:142-9.
Arber DA, George TI. Bone marrow biopsy involvement by non-Hodgkin’s lymphoma: frequency of lymphoma types, patterns, blood involvement, and discordance with other sites in 450 specimens. Am J Surg Pathol 2005;29:1549-57.
Grogg KL, Morice WG, Macon WR. Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma. Br J Haematol 2007;137:416-22.
Todorovic M, Pavlovic M, Balint B, et al. Immunophenotypic profile and clinical characteristics in patients with advanced stage mantle cell lymphoma. Med Oncol 2007;24:413-8.
Canioni D, Brice P, Lepage E, et al. Bone marrow histological patterns can predict survival of patients with grade 1 or 2 follicular lymphoma: a study from the Groupe d’Etude des Lymphomes Folliculaires. Br J Haematol 2004;126:364-71.
Chung R, Lai R, Wei P, et al. Concordant but not discordant bone marrow involvement in diffuse large B-cell lymphoma predicts a poor clinical outcome independent of the International Prognostic Index. Blood 2007;110:1278-82.
Campbell J, Seymour JF, Matthews J, Wolf M, Stone J, Juneja S. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement. Eur J Haematol 2006;76:473-80.
Hodges GF, Lenhardt TM, Cotelingam JD. Bone marrow involvement in large-cell lymphoma. Prognostic implications of discordant disease. Am J Clin Pathol 1994;101:305-11.
Domingo A, Gonzalez-Barca E, Castellsague X, et al. Expression of adhesion molecules in 113 patients with B-cell chronic lymphocytic leukemia: relationship with clinico-prognostic features. Leuk Res 1997;21:67-73.
Angelopoulou MK, Kontopidou FN, Pangalis GA. Adhesion molecules in B-chronic lymphoproliferative disorders. Semin Hematol 1999;36:178-97.
Jones D, Benjamin RJ, Shahsafaei A, Dorfman DM. The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood 2000;95:627-32.
Marcelli C, Chappard D, Rossi JF, et al. Histologic evidence of an abnormal bone remodeling in B-cell malignancies other than multiple myeloma. Cancer 1988;62:1163-70.
Vega F, Medeiros LJ, Lang WH, Mansoor A, Bueso-Ramos C, Jones D. The stromal composition of malignant lymphoid aggregates in bone marrow: variations in architecture and phenotype in different B-cell tumours. Br J Haematol 2002;117:569-76.
Krishnan C, Twist CJ, Fu T, Arber DA. Detection of isolated tumor cells in neuroblastoma by immunohistochemical analysis in bone marrow biopsy specimens: improved detection with use of beta-catenin. Am J Clin Pathol 2009;131:49-57.
Korper S, Hutter G, Blau W, et al. Successful treatment of partial graft failure after matched unrelated donor stem cell transplantation by a combination of ancestim (stem cell factor) and granulocyte colony stimulating factor in a patient with heavily pre-treated chronic lymphocytic leukemia. Leuk Lymphoma 2008;49:2015-7.
Foucar K, Viswanatha DS, Wilson CS. In: Atlas of nontumor pathology: Non-neoplastic disorders of bone marrow. ARP Press, 2008:397-8.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Jones, D., Miranda, R.N. (2010). The Bone Marrow in Normal and Disease States. In: Jones, D. (eds) Neoplastic Hematopathology. Contemporary Hematology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-384-8_5
Download citation
DOI: https://doi.org/10.1007/978-1-60761-384-8_5
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-383-1
Online ISBN: 978-1-60761-384-8
eBook Packages: MedicineMedicine (R0)